Home  |  Contact
Due to work on this service, it may not be fully operational on Wednesday March 20 between 1.30 pm and 2.30 pm CEST. Apologies for the inconvenience.
PROSITE documentation PDOC00929 [for PROSITE entry PS01209]

LDL-receptor class A (LDLRA) domain signature and profile


Low-density lipoprotein (LDL) receptors are the major cholesterol-carrying lipoproteins of plasma. Seven successive cysteine-rich repeats of about 40 amino acids are present in the N-terminal of this multidomain membrane protein [1]. Similar domains have been found (see references in [2]) in other extracellular and membrane proteins which are listed below:

  • Vertebrate very low density lipoprotein (VLDL) receptor, which binds and transports VLDL. Its extracellular domain is composed of 8 LDLRA domains, 3 EGF-like domains and 6 LDL-receptor class B domains (LDLRB).
  • Vertebrate low-density lipoprotein receptor-related protein 1 (LRP1) (reviewed in [3]), which may act as a receptor for the endocytosis of extracellular ligands. LRP1 contains 31 LDLRA domains and 22 EGF-like domains.
  • Vertebrate low-density lipoprotein receptor-related protein 2 (LRP2) (also known as gp330 or megalin). LRP2 contains 36 LDLRA domains and 17 EGF-like domains.
  • A LRP-homolog from Caenorhabditis elegans, which contains 35 LDLRA domains and 17 EGF-like domains.
  • Drosophila putative vitellogenin receptor, with 13 copies of LDLRA domains and 17 EGF-like repeats.
  • Complement factor I, which is responsible for cleaving the α-chains of C4b and C3b. It consists of a FIMAC domain (Factor I/MAC proteins C6/C7), a scavenger receptor-like domain, 2 copies of LDLRA and a C-terminal serine protease domain.
  • Complement components C6, C7, C8 and C9. They contain each one LDLRA domain.
  • Perlecan, a large multidomain basement membrane heparan sulfate proteoglycan composed of 4 LDLRA domains, 3 LamB domains, 12 laminin EGF- like domains, 14-21 IG-like domains, 3 LamG domains, and 4 EGF-like domains. A similar but shorter proteoglycan (UNC52) is found in Caenorhabditis elegans which has 3 repeats of LDLRA.
  • Invertebrate giant extracellular hemoglobin linker chains, which allow heme-containing chains to construct giant hemoglobin (1 LDLRA domain).
  • G-protein coupled receptor Grl101 of the snail Lymnaea stagnalis, which might directly transduce signals carried by large extracellular proteins.
  • Vertebrate enterokinase (EC, a type II membrane protein of the intestinal brush border, which activates trypsinogen. It consists at least of a catalytic light chain and a multidomain heavy chain which has 2 LDLRA, a MAM domain (see <PDOC00604>), a SRCR domain (see <PDOC00348>) and a CUB domain (see <PDOC00908>).
  • Human autosomal dominant polycystic kidney disease protein 1 (PKD1), which is involved in adhesive protein-protein and protein-carbohydrate interactions. The potential calcium-binding site of its single LDLRA domain is missing.
  • Vertebrate integral membrane protein DGCR2/IDD, a potential adhesion receptor with 1 LDLRA domain, a C-type lectin and a VWFC domain (see <PDOC00928>).
  • Drosophila serine protease nudel (EC 3.4.21.-), which is involved in the induction of dorsoventral polarity of the embryo. It has 11 LDLRA domains, 3 of which miss the first disulfide bond (C1-C3).
  • Avian subgroup A rous sarcoma virus receptor (1 copy of LDLRA).
  • Bovine Sco-spondin, which is secreted by the subcommissural organ in embryos and is involved in the modulation of neuronal aggregation. It contains at least 2 EGF-like domains and 3 LDLRA domains.

The LDL-receptor class A domain contains 6 disulfide-bound cysteines [4] and a highly conserved cluster of negatively charged amino acids, of which many are clustered on one face of the module [2]. A schematic representation of this domain is shown here:

     +---------------------+        +--------------------------------+
     |                     |        |                                |
                  |        *******************************************
                  |                            |
'C': conserved cysteine involved in a disulfide bond.
'x': any residue.
'*': position of the pattern.

In LDL-receptors the class A domains form the binding site for LDL [1] and calcium [5]. The acidic residues between the fourth and sixth cysteines are important for high-affinity binding of positively charged sequences in LDLR's ligands [6]. The repeat has been shown [2] to consist of a β-hairpin structure followed by a series of β turns. The binding of calcium seems to induce no significant conformational change.

Last update:

April 2006 / Pattern revised.

Technical section

PROSITE methods (with tools and information) covered by this documentation:

LDLRA_1, PS01209; LDL-receptor class A (LDLRA) domain signature  (PATTERN)

LDLRA_2, PS50068; LDL-receptor class A (LDLRA) domain profile  (MATRIX)


1AuthorsYamamoto T. Davis C.G. Brown M.S. Schneider W.J. Casey M.L. Goldstein J.L. Russell D.W.
TitleThe human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA.
SourceCell 39:27-38(1984).
PubMed ID6091915

2AuthorsDaly N.L. Scanlon M.J. Djordjevic J.T. Kroon P.A. Smith R.
TitleThree-dimensional structure of a cysteine-rich repeat from the low-density lipoprotein receptor.
SourceProc. Natl. Acad. Sci. U.S.A. 92:6334-6338(1995).
PubMed ID7603991

3AuthorsKrieger M. Herz J.
TitleStructures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).
SourceAnnu. Rev. Biochem. 63:601-637(1994).
PubMed ID7979249

4AuthorsBieri S. Djordjevic J.T. Daly N.L. Smith R. Kroon P.A.
TitleDisulfide bridges of a cysteine-rich repeat of the LDL receptor ligand-binding domain.
SourceBiochemistry 34:13059-13065(1995).
PubMed ID7548065

5Authorsvan Driel I.R. Goldstein J.L. Suedhof T.C. Brown M.S.
SourceJ. Biol. Chem. 262:17443-17449(1987).

6AuthorsMahley R.W.
TitleApolipoprotein E: cholesterol transport protein with expanding role in cell biology.
SourceScience 240:622-630(1988).
PubMed ID3283935

PROSITE is copyright. It is produced by the SIB Swiss Institute Bioinformatics. There are no restrictions on its use by non-profit institutions as long as its content is in no way modified. Usage by and for commercial entities requires a license agreement. For information about the licensing scheme send an email to
Prosite License or see: prosite_license.html.


View entry in original PROSITE document format
View entry in raw text format (no links)